Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota.
Rush University Medical Center, Chicago, Illinois.
Cancer. 2021 Dec 1;127(23):4339-4347. doi: 10.1002/cncr.33826. Epub 2021 Aug 10.
People who have advanced myelodysplastic syndromes (MDS) may live longer if they get a bone marrow transplant (BMT) instead of other therapies. However, only 15% of people with MDS actually get BMT. Experts say community physicians and transplant physicians should team up with insurance companies and patient advocacy groups to 1) spread this news about lifesaving advances in BMT, 2) ensure that everyone can afford health care, 3) provide emotional support for patients and families, 4) help patients and families get transportation and housing if they need to travel for transplant, and 5) improve care for people of under-represented racial and ethnic backgrounds.
对于患有骨髓增生异常综合征（MDS）的人来说，如果他们进行骨髓移植（BMT）而不是其他治疗，可能会活得更久。然而，实际上只有 15%的 MDS 患者接受了 BMT。专家表示，社区医生和移植医生应该与保险公司和患者权益组织合作，1）传播关于 BMT 中挽救生命的进展的消息，2）确保每个人都能负担得起医疗保健，3）为患者和家属提供情感支持，4）帮助患者和家属在需要进行移植时获得交通和住房，以及 5）改善代表性不足的种族和族裔背景的人的护理。
